Clinical trials

  • JNJ-87801493 for Non-Hodgkin lymphoma
  • DAZODALIBEP for Sjögren's syndrome|Sjögren's syndrome with moderate-to-severe symptom state
  • GUSELKUMAB for Psoriatic arthritis
  • Risdiplam for Spinal muscular atrophy
  • loncastuximab tesirine for Diffuse large B-cell lymphoma|Relapsed or refractory diffuse large B-cell lymphoma
  • UPADACITINIB for Atopic dermatitis | Moderate to severe atopic dermatitis
  • OBINUTUZUMAB for Idiopathic nephrotic syndrome (childhood-onset)
  • ATEZOLIZUMAB for High-risk hepatocellular carcinoma (HCC)|Hepatocellular carcinoma
  • BELZUPACAP SAROTALOCAN for Primary indeterminate lesion | Small choroidal melanoma
  • EMIPLACEL for Knee osteoarthritis | Osteoarthritis
  • CAPECITABINE (capecitabine) for Triple negative breast cancer | Residual disease after neoadjuvant chemo-immunotherapy
  • Atorvastatin for Graves ophthalmopathy|Graves' disease